[{"address1": "1895 Mount Hope Avenue", "city": "Rochester", "state": "NY", "zip": "14620", "country": "United States", "phone": "585 271 2700", "fax": "585 271 2765", "website": "https://www.vaccinex.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. It is developing Pepinemab, which is in phase 2 clinical for the treatment of Alzheimer's disease and has completed phase 2 study for the treatment of Huntington's disease; Pepinemab in combination with Pembrolizumab in phase 2 study for head and neck cancer; Pepinemab in combination with Avelumab in phase 2 study for pancreatic cancer, and completed phase 2 clinical trial with Avelumab for non-small cell lung cancer; and Pepinemab in combination with Nivolumab and/or Ipilimumab which is in phase 2 clinical trial for melanoma; Pepinemab in combination with Trastuzumab and dendritic cell vaccines in phase 2 clinical trial for breast cancer. The company has also developed ActivMAb, a human antibody discovery platform based on a novel method for expressing and presenting complex multipass membrane proteins, as well as full-length human monoclonal antibodies on the surface of mammalian pox viruses. In addition, it develops CHS-114 and anti-CCR8 antibody; and VX5, which is in preclinical development to treat related to autoimmune disorders.It has collaborations with Merck Sharp & Dohme; Ares Trading S.A.; Emory University; Huntington Study Group; Catalent Pharma Solutions, LLC; and Surface Oncology, Inc. The company was incorporated in 2001 and is headquartered in Rochester, New York.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maurice  Zauderer Ph.D.", "age": 78, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 437286, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elizabeth E. Evans Ph.D.", "age": 52, "title": "COO and Senior VP of Discovery & Translational Medicine", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 309408, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ernest S. Smith Ph.D.", "age": 52, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 339881, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jill  Sanchez CPA", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.45, "open": 0.7285, "dayLow": 0.36, "dayHigh": 0.7285, "regularMarketPreviousClose": 0.45, "regularMarketOpen": 0.7285, "regularMarketDayLow": 0.36, "regularMarketDayHigh": 0.7285, "payoutRatio": 0.0, "beta": 0.814, "forwardPE": -5.0, "volume": 1007, "regularMarketVolume": 1007, "averageVolume": 1628, "averageVolume10days": 2540, "averageDailyVolume10Day": 2540, "bid": 0.61, "ask": 0.7, "bidSize": 4700, "askSize": 4011, "marketCap": 1873645, "fiftyTwoWeekLow": 0.25, "fiftyTwoWeekHigh": 4.73, "allTimeHigh": 2568.3, "allTimeLow": 0.25, "priceToSalesTrailing12Months": 3.1175458, "fiftyDayAverage": 0.6178, "twoHundredDayAverage": 0.78455, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2453969, "profitMargins": 0.0, "floatShares": 1180129, "sharesOutstanding": 2676637, "sharesShort": 62111, "sharesShortPriorMonth": 127496, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0232, "heldPercentInsiders": 0.11505, "heldPercentInstitutions": 0.45013002, "shortRatio": 0.6, "shortPercentOfFloat": 0.0323, "impliedSharesOutstanding": 2676638, "bookValue": -1.552, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -18634000, "trailingEps": -8.88, "forwardEps": -0.14, "lastSplitFactor": "1:14", "lastSplitDate": 1708387200, "enterpriseToRevenue": 4.083, "enterpriseToEbitda": -0.132, "52WeekChange": -0.7826087, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 0.7, "recommendationKey": "none", "totalCash": 1107000, "totalCashPerShare": 0.414, "ebitda": -18641000, "totalDebt": 25000, "quickRatio": 0.383, "currentRatio": 0.498, "totalRevenue": 601000, "revenuePerShare": 0.286, "returnOnAssets": -3.7608402, "grossProfits": -11944000, "freeCashflow": -11543625, "operatingCashflow": -16186000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -15.90141, "financialCurrency": "USD", "symbol": "VCNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "longName": "Vaccinex, Inc.", "fiftyDayAverageChange": 0.08219999, "fiftyDayAverageChangePercent": 0.13305275, "twoHundredDayAverageChange": -0.08455002, "twoHundredDayAverageChangePercent": -0.10776881, "priceToBook": -0.4510309, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1762549200, "exchange": "PNK", "messageBoardId": "finmb_11044719", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1533821400000, "regularMarketChange": 0.25, "regularMarketDayRange": "0.36 - 0.7285", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 1628, "fiftyTwoWeekLowChange": 0.45, "fiftyTwoWeekLowChangePercent": 1.8, "fiftyTwoWeekRange": "0.25 - 4.73", "fiftyTwoWeekHighChange": -4.03, "fiftyTwoWeekHighChangePercent": -0.8520085, "fiftyTwoWeekChangePercent": -78.26087, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -8.88, "epsForward": -0.14, "regularMarketChangePercent": 55.555557, "regularMarketPrice": 0.7, "shortName": "Vaccinex, Inc.", "displayName": "Vaccinex", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]